发明授权
US07456194B2 Imidazo-fused oxazolo [4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
有权
咪唑并恶唑并[4,5-b]吡啶和咪唑并稠合的噻唑并[4,5-b]吡啶三环化合物和包含它们的药物组合物
- 专利标题: Imidazo-fused oxazolo [4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
- 专利标题(中): 咪唑并恶唑并[4,5-b]吡啶和咪唑并稠合的噻唑并[4,5-b]吡啶三环化合物和包含它们的药物组合物
-
申请号: US11272401申请日: 2005-11-10
-
公开(公告)号: US07456194B2公开(公告)日: 2008-11-25
- 发明人: Alaric Dyckman , William J. Pitts , Makonen Belema , Patrice Gill , James Kempson , Yuping Qiu , Claude Quesnelle , Steven H. Spergel , F. Christopher Zusi
- 申请人: Alaric Dyckman , William J. Pitts , Makonen Belema , Patrice Gill , James Kempson , Yuping Qiu , Claude Quesnelle , Steven H. Spergel , F. Christopher Zusi
- 申请人地址: US NJ Princeton
- 专利权人: Bristol-Myers Squibb Company
- 当前专利权人: Bristol-Myers Squibb Company
- 当前专利权人地址: US NJ Princeton
- 代理商 Mary Van Atten
- 主分类号: A61K31/4365
- IPC分类号: A61K31/4365 ; A61K31/437 ; C07D471/14 ; C07D471/16
摘要:
The present invention provides for pyrazolopurine-based tricyclic compounds having the formula (I), wherein R1, R2, R3, and R6 are as described herein. The present invention further provides pharmaceutical compositions comprising such compounds, as well as the use of such compounds for treating inflammatory and immune diseases.
公开/授权文献
信息查询
IPC分类: